Evolent Health (EVH) Equity Average (2014 - 2026)

Evolent Health's Equity Average history runs 13 years deep, the most recent figure standing at $405.8 million for Q1 2026.

• In Q1 2026, Equity Average fell 58.1% year-over-year to $405.8 million; the TTM figure through Mar 2026 stood at $405.8 million (down 58.1% YoY), while the FY2025 annual figure was $708.2 million, down 31.54% from the prior year.
• Equity Average was $405.8 million for Q1 2026 at Evolent Health, down from $628.7 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $1.1 billion in Q2 2023 to a low of $405.8 million in Q1 2026.
• Historically, Equity Average has averaged $887.9 million across 5 years, with a median of $968.4 million in 2025.
• The sharpest annual moves came in 2023 and 2026: Equity Average surged 80.92% in 2023, then plunged 58.1% in 2026.
• A 5-year view of Equity Average shows it stood at $857.8 million in 2022, then advanced by 26.13% to $1.1 billion in 2023, then declined by 5.72% to $1.0 billion in 2024, then slumped by 38.36% to $628.7 million in 2025, then tumbled by 35.46% to $405.8 million in 2026.
• The last three Equity Average figures came in at $405.8 million (Q1 2026), $628.7 million (Q4 2025), and $869.1 million (Q3 2025), per Business Quant data.